Business class action lawsuit

Medpace Faces Shareholder Class Action Lawsuit

Analysis based on 15 articles · First reported Apr 07, 2026 · Last updated Apr 17, 2026

Sentiment

-20

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The class action lawsuit against Medpace Holdings, Inc. is expected to negatively impact Medpace's stock price and reputation due to allegations of misleading statements and artificial share price inflation. This event highlights the risks associated with corporate governance and financial reporting for publicly traded companies.

Pharmaceuticals Legal Services

Event Summary

The Schall Law Firm has filed a class action lawsuit against Medpace Holdings, Inc. on behalf of investors who purchased the company's securities between April 22, 2025, and February 9, 2026. The lawsuit alleges that Medpace made false and misleading statements and engaged in a scheme to artificially inflate its share price, leading to investor losses. The firm encourages affected shareholders to contact them before June 5, 2026, to participate in the lawsuit. The case is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated by the United States===United States Securities and Exchange Commission.

Key Actions

100 The Schall Law Firm filed a class action lawsuit Medpace

90 Medpace allegedly made false and misleading statements

Entities Involved

stock

Medpace

Medpace is facing a class action lawsuit for allegedly making false and misleading statements to the market and engaging in a scheme to artificially inflate its share price. This could lead to significant financial penalties and reputational damage.

Importance 100 Sentiment -50

priv

Rosen Law Firm

Rosen Law Firm is initiating and representing investors in the class action lawsuit against Medpace. This event enhances their reputation as a leading investor rights law firm and could result in substantial legal fees.

Importance 80 Sentiment 60

priv

The Schall Law Firm

The Schall Law Firm is representing investors in a class action lawsuit against Medpace Holdings, Inc. This event provides business for the firm and enhances its reputation in shareholder rights litigation.

Importance 70 Sentiment 20

per

Brian Schall

Brian Schall is an attorney at The Schall Law Firm and is actively involved in the class action lawsuit against Medpace. His involvement highlights his role in shareholder rights litigation.

Importance 60 Sentiment 20

govactor

United States===United States Securities and Exchange Commission

The United States===United States Securities and Exchange Commission promulgates the rules under which the class action lawsuit against Medpace is being brought, specifically §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5.

Importance 30 Sentiment 0

per

Lawrence Rosen

Lawrence Rosen is a founding partner of Rosen Law Firm, which is leading the class action lawsuit against Medpace. His involvement reinforces the firm's expertise in securities class actions.

Importance 30 Sentiment 50

per

Philip Kim

Philip Kim is an attorney at Rosen Law Firm, involved in the Medpace class action lawsuit. His role is to provide information and guidance to potential class members.

Importance 30 Sentiment 50

Relationships

Medpace related ↔ The Schall Law Firm

Lawrence Rosen related ↔ Rosen Law Firm

Philip Kim related ↔ Rosen Law Firm

Medpace related ↔ Rosen Law Firm

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard